Eukaryotic cytochromes P450 (P450s) are ubiquitous, integral membrane enzymes that catalyze the mono-oxygenation of a large number of both exogenous and endogenous compounds. These reactions include pathways for the purging of environmental toxins and carcinogens, the synthesis of sterols, steroids and prostanoids and, in some cases, the metabolic activation of chemical carcinogens. Both mitochondrial and microsomal P450s are synthesized with leader sequences that target them to their respective membranes. Truncation mutants lacking the N-terminal membrane sequence are still associated with membranes when expressed in Escherichia coli or yeast, suggesting that microsomal P450s contain additional membrane binding domains that may be similar to those of mitochondrial P450s. We have made a N-terminal deletion mutant of P450 2C5, into which we have introduced further mutations in a domain which is suspected to be involved in internal membrane binding. These additional mutations prevent membrane association and promote solubility in the absence of detergents, whilst the molecule retain catalytic activities (hydroxylation of progesterone) that are highly similar to those of the unmodified enzyme. Several of these engineered P450s have proved suitable for crystallization, and we have grown large crystals (0.5 x 0.5 x 0.3 mm3) that diffract X-rays to a resolution of 2.9A. By utilizing anomalous scattering from the heme iron in muldwavelength anomalous dispersion (MAD) experiments, we have located the iron and cross- phased single-site gold derivative. Initial intermediate- resolution (3.3A) electron density maps reveal that despite exhibiting a similar overall fold to the bacterial P450s, the structure of this mammalian, microsomal P450 is also significantly different. A large number of laboratories study microsomal P450s and will benefit greatly from a structural model. We propose to continue these crystallographic studies of mammalian P450s to high resolution in order to further characterize the membrane attachment surface, to detail the conformational changes that occur when substrate binds and when the complex is reduced, determine what changes occur in the structure of the protein that when substrate binds and the complex is reduced, and to extend the crystallization methodology to related microsomal P450s of pharmaceutical interest. The structures to be determined in these studies will address questions about the interaction of P450 with the membrane and with P450 reductase, as well as substrate binding and recognition. In addition, these studies will yield significant new information regarding modes of membrane binding, and may help to advance the methodology enabling the engineering of membrane proteins for structural studies.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM059229-03
Application #
6519998
Study Section
Metallobiochemistry Study Section (BMT)
Program Officer
Chin, Jean
Project Start
2000-05-01
Project End
2004-04-30
Budget Start
2002-05-01
Budget End
2004-04-30
Support Year
3
Fiscal Year
2002
Total Cost
$273,312
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Schoch, Guillaume A; Yano, Jason K; Wester, Michael R et al. (2004) Structure of human microsomal cytochrome P450 2C8. Evidence for a peripheral fatty acid binding site. J Biol Chem 279:9497-503
Johnson, Eric F (2003) The 2002 Bernard B. Brodie Award lecture: deciphering substrate recognition by drug-metabolizing cytochromes P450. Drug Metab Dispos 31:1532-40
Scott, Emily E; He, You Ai; Wester, Michael R et al. (2003) An open conformation of mammalian cytochrome P450 2B4 at 1.6-A resolution. Proc Natl Acad Sci U S A 100:13196-201
Wester, Michael R; Johnson, Eric F; Marques-Soares, Cristina et al. (2003) Structure of a substrate complex of mammalian cytochrome P450 2C5 at 2.3 A resolution: evidence for multiple substrate binding modes. Biochemistry 42:6370-9
Wester, Michael R; Stout, C David; Johnson, Eric F (2002) Purification and crystallization of N-terminally truncated forms of microsomal cytochrome P450 2C5. Methods Enzymol 357:73-9
Johnson, Eric F; Wester, Michael R; Stout, C David (2002) The structure of microsomal cytochrome P450 2C5: a steroid and drug metabolizing enzyme. Endocr Res 28:435-41
Williams, P A; Cosme, J; Sridhar, V et al. (2000) Microsomal cytochrome P450 2C5: comparison to microbial P450s and unique features. J Inorg Biochem 81:183-90